thegoldenzebra.org

Welcome to Our World

We believe in creating meaningful experiences that inspire and connect. This biotechnology project design will theoretically utilize combined antibody fragments and a patient's own immune system to "target & starve a cancer from within." An activator will be utilized to stimulate the T Cells of the human immune system to coagulate the growing blood supply of breast cancer (or any other type of solid tumor) resulting in infarction (death) of the cancer, while theoretically leaving normal tissue (without growing blood vessels) unharmed.

Quality First

We deliver exceptional results in everything we do, ensuring your satisfaction at every step.

Expert Care

Our experienced team brings skill and passion to every project, no matter the size.

Real Results

Proven outcomes that speak for themselves and make a meaningful difference for people.

Video

CURE BREAST CANCER

QUESTIONS

1) What would it be like if we cured a human breast cancer (or any other type of cancer) that had been transplanted into a mouse and then entered human clinical trials?

2) What would it be like to become rich while we were doing that? Simply go to www.SilverZebra.us

Note: An antibody is a protein produced by the immune system that identifies and neutralizes foreign substances like bacteria, viruses, and other bad things such as a cancer cell. Antibodies recognize specific antigens (foreign molecules) and bind to them, marking them for destruction by other immune cells or directly neutralizing them. This relates to our work in immunotherapy, where we harness the power of the immune system to fight cancer and other diseases using engineered immune cells and novel approaches.

BIOTECHNOLOGY

The Chief Science Officer of this Foundation is working with the Brekken Lab at the University of Texas Southwestern, a premier cancer laboratory that is funded by the National Institutes of Health (NIH). We are working on targeting the blood vessels of a human breast cancer transplanted into a mouse (that is immunodeficient - lacking an immune system) in conjunction with Creative Biolabs in New York. We will also collaborate with the lab of Cassian Yee, Ph.D. at MD Anderson Cancer Center in Houston. Human trials await the pending results in that mouse model engrafted with a human breast cancer.